Cargando…

Effects of Urolithin A on Mitochondrial Parameters in a Cellular Model of Early Alzheimer Disease

(1) Background: Ellagitannins are natural products occurring in pomegranate and walnuts. They are hydrolyzed in the gut to release ellagic acid, which is further metabolized by the microflora into urolithins, such as urolithin A (UA). Accumulation of damaged mitochondria is a hallmark of aging and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Esselun, Carsten, Theyssen, Ellen, Eckert, Gunter P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347929/
https://www.ncbi.nlm.nih.gov/pubmed/34361099
http://dx.doi.org/10.3390/ijms22158333
_version_ 1783735213497516032
author Esselun, Carsten
Theyssen, Ellen
Eckert, Gunter P.
author_facet Esselun, Carsten
Theyssen, Ellen
Eckert, Gunter P.
author_sort Esselun, Carsten
collection PubMed
description (1) Background: Ellagitannins are natural products occurring in pomegranate and walnuts. They are hydrolyzed in the gut to release ellagic acid, which is further metabolized by the microflora into urolithins, such as urolithin A (UA). Accumulation of damaged mitochondria is a hallmark of aging and age-related neurodegenerative diseases. In this study, we investigated the neuroprotective activity of the metabolite UA against mitochondrial dysfunction in a cellular model of early Alzheimer disease (AD). (2) Methods: In the present study we used SH-SY5Y-APP695 cells and its corresponding controls (SH-SY5Ymock) to assess UA’s effect on mitochondrial function. Using these cells we investigated mitochondrial respiration (OXPHOS), mitochondrial membrane potential (MMP), adenosine triphosphate (ATP) production, autophagy and levels of reactive oxygen species (ROS) in cells treated with UA. Furthermore, we assessed UA’s effect on the expression of genes related to mitochondrial bioenergetics, mitochondrial biogenesis, and autophagy via quantitative real-time PCR (qRT-PCR). (3) Results: Treatment of SH-SY5Y-APP695 cells suggests changes to autophagy corresponding with qRT-PCR results. However, LC3B-I, LC3B-II, and p62 levels were unchanged. UA (10 µM) reduced MMP, and ATP-levels. Treatment of cells with UA (1 µM) for 24 h did not affect ROS production or levels of Aβ, but significantly increased expression of genes for mitochondrial biogenesis and OXPHOS. Mitochondrial Transcription Factor A (TFAM) expression was specifically increased in SH-SY5Y-APP695. Both cell lines showed unaltered levels of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α), which is commonly associated with mitochondrial biogenesis. Results imply that biogenesis might be facilitated by estrogen-related receptor (ESRR) genes. (4) Conclusion: Urolithin A shows no effect on autophagy in SH-SY5Y-APP695 cells and its effect on mitochondrial function is limited. Instead, data suggests that UA treatment induces hormetic effects as it induces transcription of several genes related to mitochondrial biogenesis.
format Online
Article
Text
id pubmed-8347929
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83479292021-08-08 Effects of Urolithin A on Mitochondrial Parameters in a Cellular Model of Early Alzheimer Disease Esselun, Carsten Theyssen, Ellen Eckert, Gunter P. Int J Mol Sci Article (1) Background: Ellagitannins are natural products occurring in pomegranate and walnuts. They are hydrolyzed in the gut to release ellagic acid, which is further metabolized by the microflora into urolithins, such as urolithin A (UA). Accumulation of damaged mitochondria is a hallmark of aging and age-related neurodegenerative diseases. In this study, we investigated the neuroprotective activity of the metabolite UA against mitochondrial dysfunction in a cellular model of early Alzheimer disease (AD). (2) Methods: In the present study we used SH-SY5Y-APP695 cells and its corresponding controls (SH-SY5Ymock) to assess UA’s effect on mitochondrial function. Using these cells we investigated mitochondrial respiration (OXPHOS), mitochondrial membrane potential (MMP), adenosine triphosphate (ATP) production, autophagy and levels of reactive oxygen species (ROS) in cells treated with UA. Furthermore, we assessed UA’s effect on the expression of genes related to mitochondrial bioenergetics, mitochondrial biogenesis, and autophagy via quantitative real-time PCR (qRT-PCR). (3) Results: Treatment of SH-SY5Y-APP695 cells suggests changes to autophagy corresponding with qRT-PCR results. However, LC3B-I, LC3B-II, and p62 levels were unchanged. UA (10 µM) reduced MMP, and ATP-levels. Treatment of cells with UA (1 µM) for 24 h did not affect ROS production or levels of Aβ, but significantly increased expression of genes for mitochondrial biogenesis and OXPHOS. Mitochondrial Transcription Factor A (TFAM) expression was specifically increased in SH-SY5Y-APP695. Both cell lines showed unaltered levels of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α), which is commonly associated with mitochondrial biogenesis. Results imply that biogenesis might be facilitated by estrogen-related receptor (ESRR) genes. (4) Conclusion: Urolithin A shows no effect on autophagy in SH-SY5Y-APP695 cells and its effect on mitochondrial function is limited. Instead, data suggests that UA treatment induces hormetic effects as it induces transcription of several genes related to mitochondrial biogenesis. MDPI 2021-08-03 /pmc/articles/PMC8347929/ /pubmed/34361099 http://dx.doi.org/10.3390/ijms22158333 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Esselun, Carsten
Theyssen, Ellen
Eckert, Gunter P.
Effects of Urolithin A on Mitochondrial Parameters in a Cellular Model of Early Alzheimer Disease
title Effects of Urolithin A on Mitochondrial Parameters in a Cellular Model of Early Alzheimer Disease
title_full Effects of Urolithin A on Mitochondrial Parameters in a Cellular Model of Early Alzheimer Disease
title_fullStr Effects of Urolithin A on Mitochondrial Parameters in a Cellular Model of Early Alzheimer Disease
title_full_unstemmed Effects of Urolithin A on Mitochondrial Parameters in a Cellular Model of Early Alzheimer Disease
title_short Effects of Urolithin A on Mitochondrial Parameters in a Cellular Model of Early Alzheimer Disease
title_sort effects of urolithin a on mitochondrial parameters in a cellular model of early alzheimer disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347929/
https://www.ncbi.nlm.nih.gov/pubmed/34361099
http://dx.doi.org/10.3390/ijms22158333
work_keys_str_mv AT esseluncarsten effectsofurolithinaonmitochondrialparametersinacellularmodelofearlyalzheimerdisease
AT theyssenellen effectsofurolithinaonmitochondrialparametersinacellularmodelofearlyalzheimerdisease
AT eckertgunterp effectsofurolithinaonmitochondrialparametersinacellularmodelofearlyalzheimerdisease